Alcoholism In Italy: An Introductive Analysis Of Consumption

Slides:



Advertisements
Similar presentations
Antibiotic Stewardship Curriculum Developed by: Vera P. Luther, M.D.
Advertisements

FROM EUROCHIP-1 TO EUROCHIP-2 EUROCHIP-2 - The action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
Introduction To Epidemiology and Physical Activity
The effect of improved HCV diagnosis and treatment on public health The effect of improved HCV diagnosis and treatment on public health P Mathurin Hôpital.
The Global Burden of Hepatitis C Dr Daniel Lavanchy World Health Organization (WHO) Geneva, Switzerland 3 rd Paris Hepatitis Conference.
Professor Eddie Kane.
Alcohol and disease Murielle Bochud, MD, PhD Assistant professor SSPH+ University Institute of Social and Preventive Medicine, Lausanne.
FACTORS HINDERING ATTITUDE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN THE NIGER DELTA, NIGERIA by AGOFURE OTOVWE and OYEWOLE OYEDIRAN.
Unintentional Fall Injuries and Deaths Among MA Older Adults, Ages 65 Years and Over Carrie Huisingh, MPH, Epidemiologist Holly Hackman, MD, MPH, Epidemiologist.
David Tyas Global HEOR - Lundbeck
The Impact of Employee Wellness on 4-Year Healthcare Costs May 14, 2009 Brian Day, Ed.D Health Plan Informatics.
The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older Dana P. Goldman, Federico Girosi et al. American Journal of Public Health November.
Surveillance report Annual Epidemiological Report on communicable diseases in Europe ECDC Surveillance Unit European Centre for Disease Prevention and.
1 A Crystal Ball: How to Improve the Health Care System Tom Closson President and CEO Ontario Hospital Association NAPAN 8th Annual Conference Sunday,
Incidence of Influenza in Ontario Following the Universal Influenza Immunization Campaign Dianne Groll PhD, University of Ottawa David J Thomson PhD, Queen’s.
1 Disability trends among elderly people in 12 OECD countries, and the implications for projections of long-term care spending Comments on Work Package.
Prevention policies as tool for NHS sustainability Vincenzo Atella Health Econometrics, Economics and Policy (HEEP)
Annual report 2010: the state of the drugs problem in Europe.
HEALTH RISKS OF DRINKING Devaunshi Doshi Beloit College, Beloit, Wisconsin Abstract I investigated how heavy drinking affects the human body. I hypothesized.
Modelling the Economic Potential of the Silver economy ING. MAREK RADVANSKÝ, PHD. 2 nd Neujobs validation event 9. A PRIL 2014, B ONN.
2007 National Healthcare Quality Report (NHQR) Health care quality continues to improve, but the rate of improvement has slowed Released March 3, 2008.
PRODUCTIVITY AND COSTS IN THE SYSTEM OF HEALTH CARE.
European Union against cancer The EUROCHIP project 1st International Cancer Control Congress Vancouver, October 2005 Public Health Program EUROPEAN.
Health Economics & Policy 2 nd Edition James W. Henderson Chapter 10 The Aging of the Population Copyright 2002, South-Western, a division of Thomson Learning,
Evidence-based priority setting for the National Health Development Plan of Thailand Walaiporn Patcharanarumol, Kanitta Bundhamcharoen, Phusit Prakongsai,
EPIDEMIOLOGY The study of the distribution and determinants of health related states and events in specified population and application of this.
Monitoring of Alcoholic Beverages Consumption in Thailand Gun Chernrungroj M.D., M.P.H., Ph.D. Non-communicable Disease Information Center, Department.
Inspiring People to Adopt Behaviors that Benefit the Community and Reduce Social Costs ServSafe TM : Benefits and Cost Reductions 4  Poor food handling.
Population prevalence of disease risk factors and economic consequences for the healthcare system - possible scenarios Inna Feldman Uppsala University.
HOW ARE PRIORITY ISSUES FOR AUSTRALIA’S HEALTH IDENTIFIED? HEALTH PRIORITIES IN AUSTRALIA.
Overview of China’s health care reform Wen Chen, Ph.D., Professor Fudan School of Public Health March 21, 2016.
Prevalence of Alcoholism and Anti-Alcohol Policy in the Russian Federation Eugenia Koshkina Director National Research Center on Addictions Ministry of.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Francia L., Gitto L., Mennini F.S., Polistena B (*). HEALTH EXPENDITURE IN OECD COUNTRIES: AN ECONOMETRIC ANALYSIS Francia L., Gitto L., Mennini F.S.,
PHP 1540: Alcohol Use and Misuse October 16, 2012 Assessing Health Effects of Drinking: Moderate drinking Global burden Relative burden Alcohol’s effects.
COUNTRY REPORT ON HEALTH STATUS LITHUANIA Jurate Klumbiene Institute for Biomedical Research Kaunas University of Medicine Meeting on adult premature mortality.
Liver cirrhosis mortality in European countries II Working Meeting on Adult Premature Mortality in European Union Warsaw, October 2006.
Results Alcohol Use Disorder Disease Management Program: Approximately three-quarters of plans (74%) reported having an alcohol disease management program.
Quality patients value sustainability partnership Value of generic medicines.
Section 1: Introduction Dr Somen Banerjee, Director of Public Health London Borough Tower Hamlets.
Estimated burden of fungal infections in Italy
Thomas F. Babor, Ph.D., MPH Dennis McCarty, Ph.D.
Prevention Diabetes.
National Health Reform is Essential
Italy - Evidence package
Problem alcohol use in the Irish population: review of current data
The link between alcohol-attributable harm and sustainable development
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
THE EFFECTIVENESS OF ANNUAL ZOLEDRONIC ACID INFUSION VERSUS ORAL BISPHOSPHONATE: A MODELLING APPROACH Terence Ong1, 2, Matthey Jones3, Opinder Sahota1.
Higher Prevalence of HbsAg among Blood Donors at a tertiary care center in greater Gwalior: A 5years study ( TTI-12 : D-1182 ) Dr. Anita Arya, Dr. Sachin.
THE ROLE OF DIFFERENT TYPES OF ALCOHOL ON THE RISK OF SELECTED CANCERS
Vitamin D status and cardio-metabolic risk factors in Saudi Arabia
Institute of Economic Affairs
Problem alcohol use in the Irish population: review of current data
Harmoko, MD#, Edward, MD #Institut Kesehatan Helvetia
Freya Vander Laenen STRUCTURED SESSION Costs of drug treatment
Table 3. Demographic characteristics and liver function profiles of study participants.M PROTECTIVE ROLE OF MICRONUTRIENTS IN CURBING NON-COMMUNICABLE.
Comparison of data from WBE with other sources
Wellington 16 the April 2014, Rehabilitation International
Prevention Diabetes Dr Abir Youssef 29/11/2018.
The Future Use of Technology in Outpatient Care Using the Computerized Patient Record to Implement Principles of Disease Management: Focus on the.
Ambulatory consumption of Antidepressant drugs in Albania Comparison between HII data and Import data   Eduard Kakariqi MD, MSc, PhD, Professor.
the case of five large hospitals in Rome, Italy
1/15/2019 Azienda Ospedaliera Universitaria Policlinico “P. Giaccone”
Demographic transition and economic growth in Benin
The impact of minimum pricing:
IoT adoption strategy in a hospital environment
Diabetes econonomy2 Amini Masoud 1397.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
How much is health spending expected to grow?
Presentation transcript:

Alcoholism In Italy: An Introductive Analysis Of Consumption and Hospitalisation Trends Aiello A1, D'Ausilio A1, Latorre E1, Toumi M2 1 Creativ Ceutical, Milano, Italy, 2 Aix-Marseille University, Marseille, France BACKGROUND Alcohol (beverage ethanol) distributes throughout the body, affecting almost all systems and altering nearly every neurochemical processes in the brain. Alcohol is likely to exacerbate most medical conditions and affects almost any medication metabolized in the liver (1). This dependence is associated with high direct and indirect health care costs and the total costs attributable to alcohol abuse disorders represent a significant proportion of national health care spending in Europe (2-6). A recent study from France has suggested that costs due to alcoholism correspond to ∼1% of the gross national product (7), while in Finland, direct health costs alone represent ∼0.6% of the gross domestic product, while total healthcare costs may reach 4.3% of the gross domestic product (8). Such as for other European Mediterranean Countries, in Italy there is a regular consumption of alcohol with a large prevalence of daily drinkers who often consume alcohol with meals, but in the last years there has been a change in this custom (9). The economic aspects of alcoholism have become increasingly important, due to rising healthcare costs for managing alcohol abuse consequences. Since health care resources are limited, the potential to reduce the alcohol condition incidence and progression as well as the cost of complications can produce important saving for the healthcare systems (10). OBJECTIVES The aim of this research is to analyse, between 2009-2014, alcohol consumption trends in Italy and the hospitalizations for acute alcoholic hepatitis, liver cirrhosis and alcoholic fatty liver. We have also analysed the ratio between alcohol consumption and hospitalizations as well as hospital expenditures. METHODS Data on alcohol consumption from the National Institute of Statistics (ISTAT) and hospital discharge data from the Ministry of Health were matched to show hospitalisations trends in Italy.(11,12) To estimate the hospitalization events, data for three DRGs (202, 205 and 206) directly related to alcohol abuse disease (acute alcoholic hepatitis, alcoholic liver cirrhosis and alcoholic fatty liver) were used. Last published National DRGs Tariffs (year 2012) were used to estimate the cost of hospitalizations, in order to show difference in Italian healthcare expenditure in the selected period (13). RESULTS From 2009 to 2014 (Table 1, Figure 1), the percentage of daily alcohol consumers (DACs) on the general population decreased from 27.0% (14,419k) to 22.7% (12,020k). A slighter decrease of people with high risk habits of alcohol consumption (HRACs) from 15.8% (8,454k) to 15.2% (8,265k) was noticed. Then from 2012 an inversion in the trend can be observed (Table 1, Figure 1). Considering hospitalizations related to liver alcohol habits in the analysed period (Table 1), a sharp decrease can be observed (from 82,713 to 59,124) and a ratio of hospitalizations can be estimated for DACs and HRACs: from 5.7‰ to 4,9‰ and from 9.8‰ to 7.2‰ respectively. The total hospital costs related to liver disease are estimated to decrease from €262,281,276 to €193,907,144 (Figure 2). Table 1. National alcohol consumption habits and hospital costs: 2009-2014 2009 2010 2011 2012 2013 2014 DACs (% on POP) 14,419K (27.0%) 14,126K (26.3%) 13,954K (25.8%) 12,801K (23.6%) 12,304K (22.7%) 12,020K (22.1%) HRACs 8,454K (15.8%) 8,624K (16.1%) 8,179K (15.2%) 7,464K (13.8%) 7,144K (13.2%) 8,265K HOSPs 82,713 78,817 72,941 67,916 63,097 59,124 HOSPs/DACs 5.7‰ 5.6‰ 5.2‰ 5.3‰ 5.1‰ 4.9‰ HOSPs/HRACs 9.8‰ 9.1‰ 8.9‰ 8.8‰ 7.2‰ Legend: Daily Alcohol Consumers (DACs), High Risk Alcohol Consumers (HRACs), Total Population (POP), Hospitalization Events (HOSPs). Figure 1. National consumption habits (%) on the total population: 2009-2014 Legend: Daily Alcohol Consumers (DACs), High Risk Alcohol Consumers (HRACs). Figure 2. Hospital Expenditure related to alcohol consumption: 2009-2014 CONCLUSIONS The results of the analysis show a slight decrease in alcohol consumption which translated in a sharp decrease of hospitalizations for liver problems alcoholism-related though HRACs have increased in recent years. Other causes should be scrutinized to confirm such results. Should such results be established, it would be important to implement policies to reduce alcohol abuse to safeguard general health and save healthcare costs REFERENCES 1. Harrison's Principles of Internal Medicine. 18th Edition. 2012. 2. Colombo GL et al. Subst Abuse Rehabil. 2012;3:73-79. 3. Rehm J et al. Lancet. 2009; 373:2223-33. 4. Schädlich PK et al. Pharmacoeconomics. 1998;13:719-30. 5. Brecht JG et al. Pharmacoeconomics. 1996;10:484-93. 6. Holder HD et al. Adv Alcohol Subst Abuse.1986;6:1-15. 7. Reynaud M et al. Alcohol Alcohol. 2001;36:89-95. 8. Hein R et al. Alcologia. 1999;11:135-43. 9. Shield et al. Substance Abuse Treatment, Prevention, and Policy. 2013;8:21 10. Palmer AJ et al. Alcohol Alcohol. 2000;35:478-92. 11. ISTAT. L’uso e l’abuso di alcol in Italia. Reports 2009-2014. 12. Ministero della Salute. I ricoveri in Italia. Reports 2009-2014. 13. Ministero della Salute. Decreto 18-10-2012. ISPOR 19th Annual European Congress 29 October- 2 November 2016 Austria Center Vienna, Vienna, Austria. PHS147